AstraZeneca Pharmaceuticals and Oxford University have stopped vaccine trials against COVID-19 in children.
Madrid, Spain (Europa Press)-Pharmaceutical companies AstraZeneca and the University of Oxford have stopped trials of the covid-19 vaccine for children, while the British Medicines Agency analyzed the possible relationship between the vaccine and thrombosis in adults.
The British media said that Professor Andrew Pollard of the University of Oxford clarified that the researchers are not worried about the safety of the trial itself, but said that they tend to wait until more information is available in this regard.
They pointed out: “Although there are no safety issues in pediatric clinical trials, we are still waiting for more information…before more vaccines are administered in trials.”
The child immunization trial started in February with about 300 volunteers. Specifically, it is evaluating whether the drug produces a strong immune response against COVID-19 in children between 6 and 17 years of age.
The study was suspended after an official from the European Medicines Agency (EMA) confirmed that AstraZeneca and Oxford vaccines had “links” to certain vaccinated thrombotic events.
EMA’s safety committee “has not reached a conclusion and is still continuing to analyze it”, and the UK regulatory agency, the Medicines and Healthcare Products Regulatory Agency (MHRA), is expected to make a ruling on the matter in the coming days. The MHRA reiterated that the benefits of the Covid-19 vaccine far outweigh the risks.